High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer
Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject s...
Saved in:
| Published in | Gynecologic oncology Vol. 129; no. 2; pp. 384 - 388 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.05.2013
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0090-8258 1095-6859 1095-6859 |
| DOI | 10.1016/j.ygyno.2013.02.001 |
Cover
| Abstract | Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts.
The study included 225 patients with cervical cancer FIGO IA2–IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared.
Metastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (>20cm3) and in the presence of LVSI.
Frozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management.
► Intra-operative frozen section examination of sentinel nodes yielded a false negative result in almost half of the cases (44%). ► The sensitivities for diagnosing macrometastases and low-volume disease (micrometastases and isolated tumour cells) were 81% and 8%, respectively. ► False negative rate of frozen section was higher in bigger tumours (>20cm3) and in the presence of LVSI. |
|---|---|
| AbstractList | Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts.
The study included 225 patients with cervical cancer FIGO IA2–IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared.
Metastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (>20cm3) and in the presence of LVSI.
Frozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management.
► Intra-operative frozen section examination of sentinel nodes yielded a false negative result in almost half of the cases (44%). ► The sensitivities for diagnosing macrometastases and low-volume disease (micrometastases and isolated tumour cells) were 81% and 8%, respectively. ► False negative rate of frozen section was higher in bigger tumours (>20cm3) and in the presence of LVSI. Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts. The study included 225 patients with cervical cancer FIGO IA2-IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared. Metastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (>20 cm3) and in the presence of LVSI. Frozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management. Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts.OBJECTIVESMetastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts.The study included 225 patients with cervical cancer FIGO IA2-IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared.METHODSThe study included 225 patients with cervical cancer FIGO IA2-IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared.Metastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (>20 cm3) and in the presence of LVSI.RESULTSMetastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (>20 cm3) and in the presence of LVSI.Frozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management.CONCLUSIONSFrozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management. AbstractObjectivesMetastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results of intra-operative SN examination would make it possible to triage patients in a one-step protocol. The studies carried out on the subject so far have, however, failed to demonstrate adequate accuracy of frozen section examination (FS) and, moreover, they only involved small cohorts. MethodsThe study included 225 patients with cervical cancer FIGO IA2–IIB in whom at least one SN has been detected and intra-operatively processed. The prevalence of macrometastases, micrometastases and isolated tumour cells (ITC) in the SN was evaluated and the results of FS and final SN ultrastaging were compared. ResultsMetastatic involvement of the SN was detected by pathologic ultrastaging in 73 cases (32.4%); macrometastases, micrometastases and ITC were found in 48, 17 and 8 patients, respectively. Intra-operative SN assessment established the SN status correctly in as few as 41 cases (56.2%), or in 49 cases (63%) if ITC had been excluded. Final ultrastaging of intra-operatively negative SN confirmed macrometastases, micrometastases, and ITC in additional 8, 18 and 8 patients, respectively. The false negative rate of FS was higher in bigger tumours (> 20 cm 3) and in the presence of LVSI. ConclusionsFrozen section examination of SN is not sufficiently reliable; it has a high false negative rate mainly due to its limited ability to detect micrometastases. A possible solution would be a more detailed intra-operative pathologic processing or two-step surgical management. |
| Author | Cibula, D. Dundr, P. Slama, J. Dusek, L. |
| Author_xml | – sequence: 1 givenname: J. surname: Slama fullname: Slama, J. email: jiri.slama@vfn.cz organization: Gynaecologic Oncology Centre, General University Hospital and 1st School of Medicine, Charles University, Prague, Czech Republic – sequence: 2 givenname: P. surname: Dundr fullname: Dundr, P. organization: Institute of Pathology, General University Hospital and 1st School of Medicine, Charles University, Prague, Czech Republic – sequence: 3 givenname: L. surname: Dusek fullname: Dusek, L. organization: Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic – sequence: 4 givenname: D. surname: Cibula fullname: Cibula, D. organization: Gynaecologic Oncology Centre, General University Hospital and 1st School of Medicine, Charles University, Prague, Czech Republic |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23395889$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk9vEzEQxS1URNPAJ0BCPnLJ4j-7XlsIpKoCilSJA3C2XHs2cdi1g70JLJ8eb9JeKkFPHmneb0Z-by7QWYgBEHpJSUUJFW-21bSeQqwYobwirCKEPkELSlSzErJRZ2hBiCIryRp5ji5y3hJCOKHsGTpnnKtGSrVA8dqvN7gzfQYcYG1GfwCczAg4drhL8Q8EnMGOPgYMv83ggznWpZshjD5Aj_tp2G1wiA4y9gHviqK0Mv7lxw22kA7emh5bE0r9HD09Lntx9y7R948fvl1dr26-fPp8dXmzsrUQ44orJ5wQSqq2bm3LmDTOOkkE4aCco43jTceJUKqm9S0UMTFcgpAttF1tHV-i16e5uxR_7iGPevDZQt-bAHGfNeWsbVlTK1Wkr-6k-9sBnN4lP5g06XuTikCdBDbFnBN02vrxaMOYjO81JXoORG_1MRA9B6IJ0yWQwvIH7P34_1PvThQUiw4eks62eGrB-VTC0C76R_j3D3jb-zDH8AMmyNu4T6G4r6nOBdBf50OZ74TyciNt-fgSvf33gEfX_wUNtc_L |
| CitedBy_id | crossref_primary_10_1016_j_ejogrb_2019_07_038 crossref_primary_10_1097_IGC_0000000000000513 crossref_primary_10_3389_fonc_2022_952347 crossref_primary_10_3748_wjg_v28_i30_4019 crossref_primary_10_1002_jso_24022 crossref_primary_10_1016_j_ygyno_2023_08_019 crossref_primary_10_1016_j_ygyno_2024_06_015 crossref_primary_10_1186_s40064_016_2927_5 crossref_primary_10_1016_j_jmig_2013_12_095 crossref_primary_10_3892_ol_2022_13368 crossref_primary_10_1016_j_ejso_2020_12_001 crossref_primary_10_1097_GCO_0000000000000133 crossref_primary_10_3390_cancers14030575 crossref_primary_10_1136_ijgc_2020_001586 crossref_primary_10_1111_1471_0528_16504 crossref_primary_10_1073_pnas_1916960117 crossref_primary_10_18632_oncotarget_13788 crossref_primary_10_3892_or_2017_5573 crossref_primary_10_1016_j_ejso_2014_09_010 crossref_primary_10_1136_ijgc_2020_002198 crossref_primary_10_1016_j_ygyno_2020_05_043 crossref_primary_10_1016_j_ygyno_2018_10_007 crossref_primary_10_1186_s13000_023_01294_z crossref_primary_10_1016_j_ygyno_2020_05_037 crossref_primary_10_1007_s00404_016_4279_3 crossref_primary_10_23736_S0026_4784_20_04634_1 crossref_primary_10_1038_bjc_2014_278 crossref_primary_10_1136_ijgc_2019_001062 crossref_primary_10_1002_jso_26899 crossref_primary_10_1016_j_remn_2018_04_003 crossref_primary_10_1016_j_ejogrb_2019_08_010 crossref_primary_10_1002_jso_25322 crossref_primary_10_1007_s13669_015_0125_z crossref_primary_10_3892_mco_2016_923 crossref_primary_10_1007_s12253_019_00727_9 crossref_primary_10_1016_j_ejso_2019_01_184 crossref_primary_10_1007_s10147_022_02197_7 crossref_primary_10_1007_s11596_018_1915_0 crossref_primary_10_1016_j_ejca_2020_06_034 crossref_primary_10_1136_ijgc_2019_001113 crossref_primary_10_17116_onkolog2015445_11 crossref_primary_10_1007_s10147_020_01838_z crossref_primary_10_1186_s12905_025_03550_4 crossref_primary_10_3390_tomography10050058 crossref_primary_10_1016_j_ygyno_2015_04_008 crossref_primary_10_1097_CCO_0000000000000863 crossref_primary_10_3109_07357907_2014_889707 crossref_primary_10_3389_fonc_2024_1435532 crossref_primary_10_5858_arpa_2019_0249_RA crossref_primary_10_1136_ijgc_2023_005206 crossref_primary_10_3892_ol_2017_5804 crossref_primary_10_1097_IGC_0000000000000738 crossref_primary_10_1016_j_ejogrb_2020_08_020 crossref_primary_10_1684_bdc_2014_1928 crossref_primary_10_1016_j_rpor_2018_04_004 crossref_primary_10_1016_j_jmig_2016_03_003 crossref_primary_10_2217_fon_2016_0260 crossref_primary_10_1016_j_remnie_2018_07_002 crossref_primary_10_1038_s41598_020_64926_0 crossref_primary_10_1016_j_eurox_2019_100085 crossref_primary_10_1136_ijgc_2019_000904 crossref_primary_10_3390_healthcare11222942 crossref_primary_10_1136_ijgc_2023_004523 crossref_primary_10_1007_s12253_020_00822_2 crossref_primary_10_1007_s10585_014_9670_5 crossref_primary_10_1002_jso_26518 crossref_primary_10_1007_s00404_019_05164_2 crossref_primary_10_1186_s13027_016_0068_7 |
| Cites_doi | 10.1016/j.ygyno.2004.01.026 10.1016/j.ygyno.2008.06.009 10.1016/0090-8258(89)90070-X 10.1016/j.ygyno.2011.08.010 10.1016/j.ygyno.2006.10.018 10.1016/j.ygyno.2011.11.037 10.1111/j.1525-1438.2006.00519.x 10.1016/j.ygyno.2009.10.049 10.1016/j.ygyno.2009.06.017 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2 10.1016/j.ygyno.2012.02.010 10.1245/ASO.2004.09.006 |
| ContentType | Journal Article |
| Copyright | 2013 Elsevier Inc. Elsevier Inc. Copyright © 2013 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2013 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2013 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ygyno.2013.02.001 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1095-6859 |
| EndPage | 388 |
| ExternalDocumentID | 23395889 10_1016_j_ygyno_2013_02_001 S0090825813000723 1_s2_0_S0090825813000723 |
| Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LG5 M29 M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU LCYCR AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c466t-39d6d66989747c7228adcd80603e9dd15d35f30699414bed6d0a38e687e7f4cd3 |
| IEDL.DBID | .~1 |
| ISSN | 0090-8258 1095-6859 |
| IngestDate | Thu Oct 02 06:55:33 EDT 2025 Thu Apr 03 06:59:14 EDT 2025 Wed Oct 01 02:58:55 EDT 2025 Thu Apr 24 23:10:56 EDT 2025 Fri Feb 23 02:28:43 EST 2024 Sun Feb 23 10:19:21 EST 2025 Tue Oct 14 19:31:11 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Lymphadenectomy Sentinel lymph node Frozen section Cervical cancer |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2013 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c466t-39d6d66989747c7228adcd80603e9dd15d35f30699414bed6d0a38e687e7f4cd3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 23395889 |
| PQID | 1327725499 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_1327725499 pubmed_primary_23395889 crossref_citationtrail_10_1016_j_ygyno_2013_02_001 crossref_primary_10_1016_j_ygyno_2013_02_001 elsevier_sciencedirect_doi_10_1016_j_ygyno_2013_02_001 elsevier_clinicalkeyesjournals_1_s2_0_S0090825813000723 elsevier_clinicalkey_doi_10_1016_j_ygyno_2013_02_001 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-05-01 |
| PublicationDateYYYYMMDD | 2013-05-01 |
| PublicationDate_xml | – month: 05 year: 2013 text: 2013-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Gynecologic oncology |
| PublicationTitleAlternate | Gynecol Oncol |
| PublicationYear | 2013 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Sakuragi, Satoh, Takeda, Hareyama, Takeda, Yamamoto (bb0025) 1999; 85 Ho, Chien, Huang, Wu, Shih, Chang (bb0005) 2004; 93 Fader, Edwards, Cost, Kanbour-Shakir, Kelley, Schwartz (bb0035) 2008; 111 Cibula, Abu-Rustum, Dusek, Zikán, Zaal, Sevcik (bb0050) 2012; 124 Cibula, Kuzel, Slama, Fischerova, Dundr, Freitag (bb0020) 2009; 115 Bats, Buénerd, Querleau, Leblanc, Darai, Morice (bb0040) 2011; 123 Lukaszuk, Liss, Gulczynski, Nowaczyk, Nakonieczny, Piatkowski (bb0010) 2007; 104 Fregnani, Latorre, Novik, Lopes, Soares (bb0055) 2006; 16 Gortzak-Uzan, Jimenez, Nofech-Mozes, Ismiil, Khalifa, Dubé (bb0060) 2010; 116 Barranger, Cortez, Grahek, Callard, Uzan, Darai (bb0015) 2004; 11 Delgado, Bundy, Fowler, Stehman, Sevin, Creasman (bb0030) 1989; 35 Slama, Dundr, Dusek, Fischerova, Pinkavova, Zikan (bb0045) 2012; 125 Lukaszuk (10.1016/j.ygyno.2013.02.001_bb0010) 2007; 104 Barranger (10.1016/j.ygyno.2013.02.001_bb0015) 2004; 11 Cibula (10.1016/j.ygyno.2013.02.001_bb0020) 2009; 115 Fader (10.1016/j.ygyno.2013.02.001_bb0035) 2008; 111 Bats (10.1016/j.ygyno.2013.02.001_bb0040) 2011; 123 Delgado (10.1016/j.ygyno.2013.02.001_bb0030) 1989; 35 Gortzak-Uzan (10.1016/j.ygyno.2013.02.001_bb0060) 2010; 116 Slama (10.1016/j.ygyno.2013.02.001_bb0045) 2012; 125 Cibula (10.1016/j.ygyno.2013.02.001_bb0050) 2012; 124 Ho (10.1016/j.ygyno.2013.02.001_bb0005) 2004; 93 Fregnani (10.1016/j.ygyno.2013.02.001_bb0055) 2006; 16 Sakuragi (10.1016/j.ygyno.2013.02.001_bb0025) 1999; 85 |
| References_xml | – volume: 116 start-page: 28 year: 2010 end-page: 32 ident: bb0060 article-title: Sentinel node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: Is it time to change the gold standard? publication-title: Gynecol Oncol – volume: 124 start-page: 496 year: 2012 end-page: 501 ident: bb0050 article-title: Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer publication-title: Gynecol Oncol – volume: 93 start-page: 458 year: 2004 end-page: 464 ident: bb0005 article-title: Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy publication-title: Gynecol Oncol – volume: 104 start-page: 721 year: 2007 end-page: 726 ident: bb0010 article-title: Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients—a prospective study publication-title: Gynecol Oncol – volume: 11 start-page: 445 year: 2004 end-page: 452 ident: bb0015 article-title: Laparoscopic sentinel node procedure for cervical cancer: impact of neodjuvant chemoradiotherapy publication-title: Ann Surg Oncol – volume: 125 start-page: 303 year: 2012 end-page: 306 ident: bb0045 article-title: Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy publication-title: Gynecol Oncol – volume: 115 start-page: 46 year: 2009 end-page: 50 ident: bb0020 article-title: Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer publication-title: Gynecol Oncol – volume: 123 start-page: 230 year: 2011 end-page: 235 ident: bb0040 article-title: SENTICOL collaborative group. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study publication-title: Gynecol Oncol – volume: 85 start-page: 1547 year: 1999 end-page: 1554 ident: bb0025 article-title: Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy publication-title: Cancer – volume: 111 start-page: 13 year: 2008 end-page: 17 ident: bb0035 article-title: Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment publication-title: Gynecol Oncol – volume: 16 start-page: 1188 year: 2006 end-page: 1194 ident: bb0055 article-title: Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix publication-title: Int J Gynecol Cancer – volume: 35 start-page: 314 year: 1989 end-page: 320 ident: bb0030 article-title: A prospective surgical pathological study of stage I squamous carcinoma of the cervix:a Gynecologic Oncology Group Study publication-title: Gynecol Oncol – volume: 93 start-page: 458 year: 2004 ident: 10.1016/j.ygyno.2013.02.001_bb0005 article-title: Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2004.01.026 – volume: 111 start-page: 13 year: 2008 ident: 10.1016/j.ygyno.2013.02.001_bb0035 article-title: Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.06.009 – volume: 35 start-page: 314 year: 1989 ident: 10.1016/j.ygyno.2013.02.001_bb0030 article-title: A prospective surgical pathological study of stage I squamous carcinoma of the cervix:a Gynecologic Oncology Group Study publication-title: Gynecol Oncol doi: 10.1016/0090-8258(89)90070-X – volume: 123 start-page: 230 year: 2011 ident: 10.1016/j.ygyno.2013.02.001_bb0040 article-title: SENTICOL collaborative group. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.08.010 – volume: 104 start-page: 721 year: 2007 ident: 10.1016/j.ygyno.2013.02.001_bb0010 article-title: Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients—a prospective study publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2006.10.018 – volume: 124 start-page: 496 year: 2012 ident: 10.1016/j.ygyno.2013.02.001_bb0050 article-title: Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.11.037 – volume: 16 start-page: 1188 year: 2006 ident: 10.1016/j.ygyno.2013.02.001_bb0055 article-title: Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix publication-title: Int J Gynecol Cancer doi: 10.1111/j.1525-1438.2006.00519.x – volume: 116 start-page: 28 year: 2010 ident: 10.1016/j.ygyno.2013.02.001_bb0060 article-title: Sentinel node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: Is it time to change the gold standard? publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2009.10.049 – volume: 115 start-page: 46 year: 2009 ident: 10.1016/j.ygyno.2013.02.001_bb0020 article-title: Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2009.06.017 – volume: 85 start-page: 1547 year: 1999 ident: 10.1016/j.ygyno.2013.02.001_bb0025 article-title: Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2 – volume: 125 start-page: 303 year: 2012 ident: 10.1016/j.ygyno.2013.02.001_bb0045 article-title: Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2012.02.010 – volume: 11 start-page: 445 year: 2004 ident: 10.1016/j.ygyno.2013.02.001_bb0015 article-title: Laparoscopic sentinel node procedure for cervical cancer: impact of neodjuvant chemoradiotherapy publication-title: Ann Surg Oncol doi: 10.1245/ASO.2004.09.006 |
| SSID | ssj0003012 |
| Score | 2.3784618 |
| Snippet | Metastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease management. The results... AbstractObjectivesMetastatic involvement of the sentinel nodes (SN) is one of the main prognostic factors in cervical cancer which determines the disease... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 384 |
| SubjectTerms | Adult Aged Carcinoma - pathology Carcinoma - surgery Cervical cancer Cohort Studies False Negative Reactions Female Frozen section Frozen Sections Hematology, Oncology, and Palliative Medicine Humans Hysterectomy Intraoperative Care Logistic Models Lymph Node Excision Lymphadenectomy Lymphatic Metastasis Middle Aged Neoplasm Micrometastasis Neoplasm Staging Obstetrics and Gynecology Pelvis Sentinel lymph node Sentinel Lymph Node Biopsy Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - surgery |
| Title | High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0090825813000723 https://www.clinicalkey.es/playcontent/1-s2.0-S0090825813000723 https://dx.doi.org/10.1016/j.ygyno.2013.02.001 https://www.ncbi.nlm.nih.gov/pubmed/23395889 https://www.proquest.com/docview/1327725499 |
| Volume | 129 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1095-6859 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003012 issn: 0090-8258 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1095-6859 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003012 issn: 0090-8258 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1095-6859 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003012 issn: 0090-8258 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Science Direct customDbUrl: eissn: 1095-6859 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003012 issn: 0090-8258 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1095-6859 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003012 issn: 0090-8258 databaseCode: AKRWK dateStart: 19721101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhhdJL6Xc3aYIKPdaNLEuydAyhYdslOZSG5iZsSQ5bFjmsN9DNIb89M7K9JbRJoScbW7JkazSasd68IeSD5MFX3NUZ6H5wUJxwWd0oljmmKjD3pZNpB__kVE3PxNdzeb5FjsZYGIRVDrq_1-lJWw9XDoaveXA5n2OML6brlho3ZFjJkfFTiBKzGHy6-Q3zAAHuGcNTyLTUI_NQwnitL9YRIwDzoifuzO9bne6zPtMqdPyMPB3MR3rY9_A52QrxBXl8MmyQvyQt4jZoAzIVaAwXidWbIhsEbRvaLNvrEGmX0FeRhl8V4mDSOdzFKCR4xoIu1jDCNLY-dHQe6cC82lH8ZUtd0i3QBYfisnxFzo4_fz-aZkNOhcwJpVZZYbzyCrNGgh_hSs515Z3XTLEiGO9z6QvZgBthjMhFHaAwqwodlC5D2Qjni9dkO7YxvCUUTAtW1hqWfGcEc6pmlVC503neCNOYZkL4-C2tGwjHMe_Fwo7Isp82DYDFAbCMI75uQj5uKl32fBsPFxfjINkxlBSUn4X14OFq5d-qhW6YwJ3NbQcl7R9CNiFqU_OOnP67yfejDFmYwbgtU8XQXkFTBQcXB_30CXnTC9fm1XlRGKm12fnfZnfJE54SeCBE8x3ZXi2vwh6YUat6P82TffLo8MtseorH2bcfs1vhch2F |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYBLxZstLyNxJNTxK_YRVVQLdHtqpd6sxHaqRSun2mylbg_97R07ziIELRK3KPHEjj0ez2S-mUHoo6De1dQ2Bch-MFAst0XTSlJYImtQ94UVyYM_O5LTE_79VJxuof0xFibCKrPsH2R6ktb5zl6ezb3z-TzG-MZy3UJFhwypKLuH7nNBq2iBfb7-hfMADh5ShqeYaaHG1EMJ5LU-W4cYAliyIXNnedvxdJv6mY6hg8doJ-uP-MswxCdoy4en6MEse8ifoS4CN3ALTOVx8GcprTeO6SBw1-J22V35gPsEvwrYX9YRCJOu4WkMQ4J3LPBiDUuMQ-d8j-cB59SrPY7_bLFNwgWGYCO_LJ-jk4Ovx_vTIhdVKCyXclUw7aSTsWwkGBK2olTVzjpFJGFeO1cKx0QLdoTWvOSNh8akZspLVfmq5daxF2g7dMG_Qhh0C1I1Cs58qzmxsiE1l6VVZdly3ep2gug4l8bmjOOx8MXCjNCynyYtgIkLYAiNALsJ-rQhOh8SbtzdnI-LZMZYUpB-Bg6Eu8mqv5H5Pu_g3pSmh5bmDy6bILmh_I1R_93lh5GHDGzh6Jepg-8uoCsGXJsM9Ql6OTDX5tMpY1oopXf_t9v36OH0eHZoDr8d_XiNHtFUzSPiNd-g7dXywr8FnWrVvEt75gZeGx13 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+false+negative+rate+of+frozen+section+examination+of+sentinel+lymph+nodes+in+patients+with+cervical+cancer&rft.jtitle=Gynecologic+oncology&rft.au=Slama%2C+J&rft.au=Dundr%2C+P&rft.au=Dusek%2C+L&rft.au=Cibula%2C+D&rft.date=2013-05-01&rft.issn=1095-6859&rft.eissn=1095-6859&rft.volume=129&rft.issue=2&rft.spage=384&rft_id=info:doi/10.1016%2Fj.ygyno.2013.02.001&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00908258%2FS0090825813X00046%2Fcov150h.gif |